The global vitamin B12 ingredient market is projected to grow from USD 0.3 million in 2025 to USD 0.5 million by 2035, registering a compound annual growth rate (CAGR) of 5.8% over the forecast period. This expansion reflects a gradual yet consistent shift toward micronutrient fortification, preventive healthcare, and increased awareness of vitamin B12 deficiency across both developed and emerging economies.
Vitamin B12 plays a critical role in energy metabolism, neurological health, red blood cell formation, and cognitive function, making it an essential ingredient across dietary supplements, pharmaceuticals, fortified foods, and functional beverages. As health-conscious consumers increasingly prioritize nutrient adequacy, the ingredient’s commercial relevance continues to strengthen.
Explore trends before investing – request a sample report today!
A detailed breakpoint analysis highlights how market growth unfolds across distinct adoption phases. In the early stage, as market value advances from USD 0.2 million to USD 0.3 million, growth is driven by initial adoption in dietary supplements and nutraceutical formulations. This first breakpoint marks the transition of vitamin B12 from niche clinical usage toward broader incorporation in mainstream health products.
The second growth phase, spanning USD 0.3 million to USD 0.4 million, reflects rising consumer awareness regarding vitamin B12’s importance for individuals following vegetarian and vegan diets, as well as aging populations susceptible to deficiency. This stage signals accelerated adoption in fortified foods and functional beverages. In the final phase, from USD 0.4 million to USD 0.5 million, the market enters a maturity stage characterized by stable, repeat demand across supplements, pharmaceuticals, and specialty nutrition products, with fewer abrupt demand spikes.
Market Snapshot and Key Metrics
- Market Value (2025): USD 0.3 million
- Forecast Value (2035): USD 0.5 million
- Forecast CAGR (2025–2035): 5.8%
- Leading Form Segment (2025): Cyanocobalamin (39.7%)
- Key Growth Regions: North America, Europe, Asia-Pacific
The vitamin B12 ingredient market is closely linked to five parent industries that collectively shape its growth trajectory. Dietary supplements and nutraceuticals dominate with approximately 40% share, supported by widespread use in capsules, tablets, powders, and liquid formulations. Functional foods and beverages contribute nearly 25%, driven by fortification of cereals, energy drinks, dairy alternatives, and meal replacements. Pharmaceuticals and clinical nutrition account for around 15%, while animal feed and pet nutrition add 12%, and biotechnology and fermentation technologies contribute the remaining 8%.
Why Is the Vitamin B12 Ingredient Market Growing?
Market growth is fueled by increasing diagnosis of micronutrient deficiencies, especially among elderly populations and individuals with restrictive diets. Rising adoption of preventive healthcare, combined with regulatory support for nutrient fortification, has strengthened demand across food, supplement, and pharmaceutical sectors. Improvements in biosynthetic and fermentation-based production technologies have also enhanced ingredient availability, quality consistency, and cost efficiency.
Segment Insights
By form, cyanocobalamin leads the market, accounting for nearly 39.7% share. Its dominance stems from chemical stability, long shelf life, regulatory acceptance, and cost-effective large-scale production. Despite rising interest in bioactive forms such as methylcobalamin, cyanocobalamin remains the preferred choice for fortified foods and mass-market supplements.
From a source perspective, animal-based vitamin B12 ingredients hold approximately 62.4% share, supported by established extraction processes, high bioavailability, and strong clinical validation. While plant-based and fermentation-derived alternatives are gaining traction among vegan consumers, animal-derived sources continue to dominate pharmaceutical and therapeutic applications.
By application, the pharmaceutical segment leads with a 21.5% share, driven by rising use of vitamin B12 in treating anemia, neuropathy, and metabolic disorders. Injectable, oral, and sublingual formulations remain central to this segment’s growth.
Regional and Country-Level Outlook
Asia-Pacific emerges as the fastest-growing region, led by China (7.8% CAGR) and India (7.3% CAGR), supported by expanding nutraceutical manufacturing, fortified food consumption, and government-led nutrition initiatives. Europe shows steady growth, with Germany growing at 6.7%, driven by aging demographics and strong regulatory frameworks. The United States, growing at 4.9% CAGR, continues to benefit from high supplement consumption and innovation in functional beverages.
Dive deeper—click here for the comprehensive report.
Competitive Landscape
The vitamin B12 ingredient market remains moderately competitive, with leading players focusing on purity standards, bioavailability, formulation flexibility, and regulatory compliance. Key companies include Adisseo, BASF SE, DSM Nutritional Products, Gnosis by Lesaffre, Jubilant Life Sciences, Lonza, Merck KGaA, Thermo Fisher Scientific, and Zhejiang Shengda Bio-Pharm, among others. Strategic investments in fermentation technology, encapsulation, and customized ingredient solutions are shaping competitive differentiation.
Key Players in the Vitamin B12 Ingredient Market
- Adisseo
- BASF SE
- DSM Nutritional Products
- Gnosis by Lesaffre
- Jubilant Life Sciences
- Lonza
- Merck KGaA
- NOW Foods
- NutraGenesis
- Nutrilo
- Pharmavit
- Rousselot
- Spectrum Chemical Manufacturing
- Thermo Fisher Scientific
- Zhejiang Shengda Bio-Pharm
Why FMI: https://www.futuremarketinsights.com/why-fmi
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization trusted by Fortune 500 companies and global enterprises. With delivery centers in the U.S., UK, India, and Dubai, FMI provides data-driven insights across 30+ industries and over 1,200 markets worldwide, enabling clients to navigate change and unlock growth opportunities.
